Serac Healthcare Limited ("Serac Healthcare" or "the Company"), a clinical radiopharmaceutical company developing an innovative molecular imaging agent, today announced positive feedback from its End ...
Acrivon Therapeutics (ACRV) announced the U.S. Food and Drug Administration, FDA, has granted Breakthrough Device designation, BDD, for the ...
Following a recent revoking of authorization by the Food and Drug Association (FDA), manufacturers choice of FD&C Red No. 3, ...
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption ...
The FDA says new labels will make it easier to spot harmful ingredients. A UVA nutritionist suggests taking a holistic ...
The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...
The company has recalled the two-pound bags of its Natural Mix that were sold in eight states after a sample tested positive ...
Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
Tonix Pharmaceuticals (TNXP) stock plunged after the company carried out a 1-for-100 reverse stock split as it awaits approval for its ...
Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.
Comment by Feb. 17 for your feedback to be reviewed by the guideline development workgroup.
Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to ...